It is increasingly discussed in longevity and preventive-medicine circles as a way to achieve: Metabolic balance without extreme appetite suppression Sustained tolerability by avoiding gastrointestinal side effects Lower cost and simplified maintenance regimens Long-term receptor engagement for cardiometabolic and neuroprotective benefits While this approach remains off-label and under formal investigation, the biological rationale is strong: GLP-1 signaling is not binary but dose-responsive, and even partial activation may influence inflammatory, vascular, and cognitive pathways linked to aging
also found that the food intake-suppressing effect of GLP-1 administered intraperitoneally was abolished in mice lacking 5-HT2C receptors, further highlighting the role of the 5-HT2C receptor in the modulation of GLP-1 effects [27]
In 2024, North America led the market, achieving over 49.7% share with a revenue of US$ 26.6 Billion
This material is not intended to be relied upon as a forecast, research or investment advice, and it is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy
Standardization of alcohol calculations in research
